LOGIN  |  REGISTER
Cue Biopharma
Amneal Pharmaceuticals

Align Technology to Speak at Upcoming Financial Conferences

May 24, 2023 | Last Trade: US$313.78 1.90 0.61

TEMPE, Ariz. / May 24, 2023 / Business Wire / Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that the company is scheduled to speak at upcoming financial conferences. The presentations, as noted below, will be webcast live via the Investor Relations section of Align Technology's website at http://investor.aligntech.com. An archived replay will remain on the website for approximately three months.

Conference:

 

Stifel 2023 Jaws & Paws Conference

Date:

 

Thursday, June 1, 2023

Presentation:

 

10:20 – 10:50 a.m. ET

Location:

 

New York, NY

Speakers:

 

John Morici, CFO

Simon Beard, EVP and Managing Director Americas, EMEA

 

Conference:

 

William Blair 43rd Annual Growth Stock Conference

Date:

 

Wednesday, June 7, 2023

Presentation:

 

8:00 – 8:30 a.m. CT

Location:

 

Chicago, IL

Speakers:

 

John Morici, CFO

Simon Beard, EVP and Managing Director Americas, EMEA

 

Conference:

 

Jefferies Global Healthcare Conference

Date:

 

Thursday, June 8, 2023

Presentation:

 

8:00 – 8:25 a.m. ET

Location:

 

New York, NY

Speakers:

 

John Morici, CFO

Simon Beard, EVP and Managing Director Americas, EMEA

 

Conference:

 

Goldman Sachs 44th Annual Global Healthcare Conference

Date:

 

Tuesday, June 13, 2023

Presentation:

 

2:40 – 3:20 p.m. PT

Location:

 

Dana Point, CA

Speakers:

 

John Morici, CFO

 

About Align Technology, Inc.

Align Technology designs and manufactures the Invisalign® System, the most advanced clear aligner system in the world, iTero™ intraoral scanners and services, and exocad™ CAD/CAM software. These technology building blocks enable enhanced digital orthodontic and restorative workflows to improve patient outcomes and practice efficiencies for approximately 243 thousand doctor customers and are key to accessing Align’s 500 million consumer market opportunity worldwide. Over the past 25 years, Align has helped doctors treat over 15.1 million patients with the Invisalign System and is driving the evolution in digital dentistry through the Align Digital Platform™, our integrated suite of unique, proprietary technologies and services delivered as a seamless, end-to-end solution for patients and consumers, orthodontists and GP dentists, and lab/partners. Visit www.aligntech.com for more information.

For additional information about the Invisalign System or to find an Invisalign doctor in your area, please visit www.invisalign.com. For additional information about the iTero digital scanning system, please visit www.itero.com. For additional information about exocad dental CAD/CAM offerings and a list of exocad reseller partners, please visit www.exocad.com.

Invisalign, iTero, exocad, Align, and Align Digital Platform are trademarks of Align Technology, Inc.

Surmodics

Stock Quote

Featured Stock

Surmodics

Surmodics is the global leader in surface modification technologies for intravascular medical devices and a leading provider of chemical components for in vitro diagnostic immunoassay tests and microarrays. Surmodics is pursuing highly differentiated whole-product solutions that are designed to address...

CLICK TO LEARN MORE

Featured Stock

Compass Therapeutics

Compass Therapeutics is a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases. The company's scientific focus is on the relationship between angiogenesis, the immune system, and tumor growth...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB